Shots: Shots: Florio GmbH has launched Florio, a digital medical device designed to improve the quality of life for people with hemophilia Florio consist of smartphone app combined with a […]readmore
Tags : Hemophilia
Shots: Enzyre to receive funding to advance its existing technology for the development of the diagnostic device, allowing hemophilia patients to automatically determine their coagulation status at home and transfer […]readmore
Shots: Sanofi acquires Bioverativ, in all stock transaction with its Eloctate & Alprolix products. Bioverativ to receive $105/share in cash for a premium of 64 % with total deal value […]readmore